Cargando…

Clinical profile of patients infected with suspected SARS-CoV-2 Omicron variant of concern, Tamil Nadu, India, December 2021-January 2022

BACKGROUND & OBJECTIVES: COVID-19 cases have been rising rapidly in countries where the SARS-CoV-2 variant of concern (VOC), Omicron (B.1.1.529) has been reported. We conducted a study to describe the epidemiological and clinical characteristics and outcomes of COVID-19 patients with ‘S’ gene ta...

Descripción completa

Detalles Bibliográficos
Autores principales: Raju, Mohan Kumar, Thangaraj, Jeromie Wesley Vivian, Selvavinayagam, T.S., Somasundaram, A., Parthipan, K., Sivadoss, Raju, Sabarinathan, R., Subramaniam, Sudharshini, Rozario, Amanda G.A., Rani, Sudha D., Suganya, E., Murhekar, Manoj V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552397/
https://www.ncbi.nlm.nih.gov/pubmed/35417991
http://dx.doi.org/10.4103/ijmr.ijmr_312_22
_version_ 1784806242177253376
author Raju, Mohan Kumar
Thangaraj, Jeromie Wesley Vivian
Selvavinayagam, T.S.
Somasundaram, A.
Parthipan, K.
Sivadoss, Raju
Sabarinathan, R.
Subramaniam, Sudharshini
Rozario, Amanda G.A.
Rani, Sudha D.
Suganya, E.
Murhekar, Manoj V.
author_facet Raju, Mohan Kumar
Thangaraj, Jeromie Wesley Vivian
Selvavinayagam, T.S.
Somasundaram, A.
Parthipan, K.
Sivadoss, Raju
Sabarinathan, R.
Subramaniam, Sudharshini
Rozario, Amanda G.A.
Rani, Sudha D.
Suganya, E.
Murhekar, Manoj V.
author_sort Raju, Mohan Kumar
collection PubMed
description BACKGROUND & OBJECTIVES: COVID-19 cases have been rising rapidly in countries where the SARS-CoV-2 variant of concern (VOC), Omicron (B.1.1.529) has been reported. We conducted a study to describe the epidemiological and clinical characteristics and outcomes of COVID-19 patients with ‘S’ gene target failure (SGTF, suspected Omicron). Furthermore, their clinical outcomes with COVID-19 patients with non-SGTF (non-Omicron) were also compared. METHODS: This study was conducted in Tamil Nadu, India, between December 14, 2021 and January 7, 2022 among patients who underwent reverse transcription-PCR testing for SARS-CoV-2 in four laboratories with facilities for S gene screening. Consecutively selected COVID-19 patients with SGTF were telephonically contacted, seven and 14 days respectively after their date of positive result to collect information on the socio-demographic characteristics, previous history of COVID-19, vaccination status and clinical course of illness along with treatment details. To compare their outcomes with non-SGTF patients, one randomly suspected non-Omicron case for every two suspected Omicron cases from the line-list were selected, matching for the date of sample collection and the testing laboratory. RESULTS: A total of 1175 SGTF COVID-19 patients were enrolled for this study. Almost 6 per cent (n=72) reported a history of previous infection. 141 (13.5%) suspected Omicron cases were non-vaccinated, while 148 (14.2%) and 703 (67.4%) had received valid one and two doses of COVID-19 vaccines, respectively. Predominant symptoms reported included fever (n=508, 43.2%), body pain (n=275, 23.4%), running nose (n=261, 22.2%) and cough (n=249, 21.2%). Five (0.4%) of the 1175 suspected Omicron cases required oxygen supplementation as compared to ten (1.6%) of the 634 suspected non-Omicron cases. No deaths were reported among omicron suspects, whereas there were four deaths among suspected non-Omicron cases. INTERPRETATION & CONCLUSIONS: Majority of the suspected Omicron cases had a mild course of illness. The overall severity of these cases was less compared to the suspected non-Omicron cases.
format Online
Article
Text
id pubmed-9552397
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-95523972022-10-12 Clinical profile of patients infected with suspected SARS-CoV-2 Omicron variant of concern, Tamil Nadu, India, December 2021-January 2022 Raju, Mohan Kumar Thangaraj, Jeromie Wesley Vivian Selvavinayagam, T.S. Somasundaram, A. Parthipan, K. Sivadoss, Raju Sabarinathan, R. Subramaniam, Sudharshini Rozario, Amanda G.A. Rani, Sudha D. Suganya, E. Murhekar, Manoj V. Indian J Med Res Original Article BACKGROUND & OBJECTIVES: COVID-19 cases have been rising rapidly in countries where the SARS-CoV-2 variant of concern (VOC), Omicron (B.1.1.529) has been reported. We conducted a study to describe the epidemiological and clinical characteristics and outcomes of COVID-19 patients with ‘S’ gene target failure (SGTF, suspected Omicron). Furthermore, their clinical outcomes with COVID-19 patients with non-SGTF (non-Omicron) were also compared. METHODS: This study was conducted in Tamil Nadu, India, between December 14, 2021 and January 7, 2022 among patients who underwent reverse transcription-PCR testing for SARS-CoV-2 in four laboratories with facilities for S gene screening. Consecutively selected COVID-19 patients with SGTF were telephonically contacted, seven and 14 days respectively after their date of positive result to collect information on the socio-demographic characteristics, previous history of COVID-19, vaccination status and clinical course of illness along with treatment details. To compare their outcomes with non-SGTF patients, one randomly suspected non-Omicron case for every two suspected Omicron cases from the line-list were selected, matching for the date of sample collection and the testing laboratory. RESULTS: A total of 1175 SGTF COVID-19 patients were enrolled for this study. Almost 6 per cent (n=72) reported a history of previous infection. 141 (13.5%) suspected Omicron cases were non-vaccinated, while 148 (14.2%) and 703 (67.4%) had received valid one and two doses of COVID-19 vaccines, respectively. Predominant symptoms reported included fever (n=508, 43.2%), body pain (n=275, 23.4%), running nose (n=261, 22.2%) and cough (n=249, 21.2%). Five (0.4%) of the 1175 suspected Omicron cases required oxygen supplementation as compared to ten (1.6%) of the 634 suspected non-Omicron cases. No deaths were reported among omicron suspects, whereas there were four deaths among suspected non-Omicron cases. INTERPRETATION & CONCLUSIONS: Majority of the suspected Omicron cases had a mild course of illness. The overall severity of these cases was less compared to the suspected non-Omicron cases. Wolters Kluwer - Medknow 2022-01 /pmc/articles/PMC9552397/ /pubmed/35417991 http://dx.doi.org/10.4103/ijmr.ijmr_312_22 Text en Copyright: © 2022 Indian Journal of Medical Research https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Raju, Mohan Kumar
Thangaraj, Jeromie Wesley Vivian
Selvavinayagam, T.S.
Somasundaram, A.
Parthipan, K.
Sivadoss, Raju
Sabarinathan, R.
Subramaniam, Sudharshini
Rozario, Amanda G.A.
Rani, Sudha D.
Suganya, E.
Murhekar, Manoj V.
Clinical profile of patients infected with suspected SARS-CoV-2 Omicron variant of concern, Tamil Nadu, India, December 2021-January 2022
title Clinical profile of patients infected with suspected SARS-CoV-2 Omicron variant of concern, Tamil Nadu, India, December 2021-January 2022
title_full Clinical profile of patients infected with suspected SARS-CoV-2 Omicron variant of concern, Tamil Nadu, India, December 2021-January 2022
title_fullStr Clinical profile of patients infected with suspected SARS-CoV-2 Omicron variant of concern, Tamil Nadu, India, December 2021-January 2022
title_full_unstemmed Clinical profile of patients infected with suspected SARS-CoV-2 Omicron variant of concern, Tamil Nadu, India, December 2021-January 2022
title_short Clinical profile of patients infected with suspected SARS-CoV-2 Omicron variant of concern, Tamil Nadu, India, December 2021-January 2022
title_sort clinical profile of patients infected with suspected sars-cov-2 omicron variant of concern, tamil nadu, india, december 2021-january 2022
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552397/
https://www.ncbi.nlm.nih.gov/pubmed/35417991
http://dx.doi.org/10.4103/ijmr.ijmr_312_22
work_keys_str_mv AT rajumohankumar clinicalprofileofpatientsinfectedwithsuspectedsarscov2omicronvariantofconcerntamilnaduindiadecember2021january2022
AT thangarajjeromiewesleyvivian clinicalprofileofpatientsinfectedwithsuspectedsarscov2omicronvariantofconcerntamilnaduindiadecember2021january2022
AT selvavinayagamts clinicalprofileofpatientsinfectedwithsuspectedsarscov2omicronvariantofconcerntamilnaduindiadecember2021january2022
AT somasundarama clinicalprofileofpatientsinfectedwithsuspectedsarscov2omicronvariantofconcerntamilnaduindiadecember2021january2022
AT parthipank clinicalprofileofpatientsinfectedwithsuspectedsarscov2omicronvariantofconcerntamilnaduindiadecember2021january2022
AT sivadossraju clinicalprofileofpatientsinfectedwithsuspectedsarscov2omicronvariantofconcerntamilnaduindiadecember2021january2022
AT sabarinathanr clinicalprofileofpatientsinfectedwithsuspectedsarscov2omicronvariantofconcerntamilnaduindiadecember2021january2022
AT subramaniamsudharshini clinicalprofileofpatientsinfectedwithsuspectedsarscov2omicronvariantofconcerntamilnaduindiadecember2021january2022
AT rozarioamandaga clinicalprofileofpatientsinfectedwithsuspectedsarscov2omicronvariantofconcerntamilnaduindiadecember2021january2022
AT ranisudhad clinicalprofileofpatientsinfectedwithsuspectedsarscov2omicronvariantofconcerntamilnaduindiadecember2021january2022
AT suganyae clinicalprofileofpatientsinfectedwithsuspectedsarscov2omicronvariantofconcerntamilnaduindiadecember2021january2022
AT murhekarmanojv clinicalprofileofpatientsinfectedwithsuspectedsarscov2omicronvariantofconcerntamilnaduindiadecember2021january2022